BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chinese Society of Hepatology, Chinese Medical Association. [Guidelines on the management of ascites and complications in cirrhosis]. Zhonghua Ganzang Bing Zazhi. 2017;25:664-677. [PMID: 29108189 DOI: 10.3760/cma.j.issn.1007-3418.2017.09.006] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
Number Citing Articles
1 Xu XY, Ding HG, Li WG, Jia JD, Wei L, Duan ZP, Liu YL, Ling-Hu EQ, Zhuang H, Hepatology CSO, Association CM. Chinese guidelines on management of hepatic encephalopathy in cirrhosis. World J Gastroenterol 2019; 25(36): 5403-5422 [PMID: 31576089 DOI: 10.3748/wjg.v25.i36.5403] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
2 Yao X, Zhou H, Huang S, Tang SH, Qin JP. Effects of transjugular intrahepatic portosystemic shunt using the Viatorr stent on hepatic reserve function in patients with cirrhosis. World J Clin Cases 2021; 9(7): 1532-1542 [PMID: 33728297 DOI: 10.12998/wjcc.v9.i7.1532] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
3 Lv XY, Ding HG, Zheng JF, Fan CL, Li L. Rifaximin improves survival in cirrhotic patients with refractory ascites: A real-world study. World J Gastroenterol 2020; 26(2): 199-218 [PMID: 31988585 DOI: 10.3748/wjg.v26.i2.199] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]